U.S. Communications Stock News

NasdaqCM:APPS
NasdaqCM:APPSSoftware

Digital Turbine Q3 Profit Challenges Ongoing Loss Narrative For APPS Investors

Digital Turbine (APPS) has just posted Q3 2026 results with revenue of US$151.4 million and Basic EPS of US$0.04, alongside net income of US$5.1 million, putting fresh numbers on a business that is still loss making over the trailing twelve months. The company has seen revenue move from US$118.7 million in Q2 2025 to US$151.4 million in Q3 2026, while quarterly Basic EPS has ranged from losses of around US$0.24 to a small profit of US$0.04, which keeps the focus firmly on how much of that top...
NasdaqGS:CYBR
NasdaqGS:CYBRSoftware

CyberArk Software (CYBR) Revenue Growth Outpaces Market Yet Losses Challenge Bullish Narratives

CyberArk Software (CYBR) has wrapped up FY 2025 with fourth quarter revenue of US$372.7 million and a basic EPS loss of US$0.34, setting the tone for a year where growth in the top line sat alongside continued pressure on earnings. Over the past few quarters, revenue has moved from US$317.6 million in Q1 2025 to US$372.7 million in Q4, while basic EPS has swung from a profit of US$0.23 in Q1 to losses of US$1.81 in Q2, US$1.00 in Q3 and US$0.34 in Q4. This highlights how revenue expansion has...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Is It Time To Reassess Viatris (VTRS) After Its Recent Share Price Strength

If you are wondering whether Viatris shares still offer value at around US$14.36, you are not alone; many investors are asking the same question right now. The stock has posted returns of 10.7% over 7 days, 16.1% over 30 days, 15.2% year to date, 37.8% over 1 year, 38.2% over 3 years and a 4.5% decline over 5 years, which has drawn attention to how the market is currently pricing the business. Recent news flow around Viatris has focused on its positioning within the pharmaceuticals and...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Teradyne (TER) Margin Decline To 17.4% Tests Bullish High Quality Earnings Narrative

Teradyne’s FY 2025 Earnings Snapshot Teradyne (TER) has wrapped up FY 2025 with fourth quarter revenue of US$1.1 billion and basic EPS of US$1.64, setting the tone for how investors assess the latest move in profitability. The company has seen quarterly revenue move from US$752.9 million in Q4 2024 to US$1.1 billion in Q4 2025, while basic EPS shifted from US$0.90 to US$1.64 over the same period, providing a clear view of how the top and bottom line have tracked together. With a trailing 12...
OTCPK:AAGF.F
OTCPK:AAGF.FMetals and Mining

Can Aftermath Silver’s New COO Elevate AAGF.F’s Mine Execution Strength Into a Clearer Investment Story?

Aftermath Silver Ltd. recently appointed mining engineer Danny Keating as Chief Operating Officer, while Michael Parker moved into a Technical Director role overseeing the Peruvian and Chilean projects. The reshaped leadership team comes as the Berenguela project enters a critical technical evaluation and de-risking phase, potentially sharpening the company’s project execution capabilities. Next, we’ll explore how this leadership shift, particularly Keating’s mine development background, may...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

Scholar Rock Insider Sales Coincide With Key Apitegromab Launch Decisions

Scholar Rock Holding's Chief Scientific Officer has executed multiple insider share sales under a pre-arranged 10b5-1 trading plan. The transactions come as the company readies apitegromab, its muscle-targeted treatment, for potential launch in the U.S. and Europe pending regulatory approvals. The timing links leadership share activity with a period of important commercialization preparations for the company. Scholar Rock Holding (NasdaqGS:SRRK) is drawing fresh attention as insider trading...
NasdaqGS:KMB
NasdaqGS:KMBHousehold Products

3 Stocks Estimated To Be Trading At Discounts Up To 44%

As the United States stock market kicks off February with a strong performance, marked by significant gains in major indices like the Dow Jones Industrial Average and the S&P 500, investors are keenly observing opportunities amidst fluctuating economic signals. In this vibrant market environment, identifying undervalued stocks can be particularly appealing as they offer potential value when trading below their intrinsic worth.
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Three Growth Stocks Insiders Are Eager To Hold

As February begins, major U.S. stock indexes have shown a strong start with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing record highs, indicating a positive market momentum. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often reflect confidence from those closest to the business in its potential for future success.
OTCPK:INIS
OTCPK:INISLife Sciences

February 2026's Top Penny Stocks To Watch

As February 2026 begins, U.S. stock markets have shown strength, with major indexes like the Dow Jones and S&P 500 posting notable gains. In this context of market optimism and economic developments, investors are exploring opportunities across various sectors. Penny stocks, despite their somewhat outdated moniker, remain relevant as they often represent smaller or newer companies that can offer unique growth potential at lower price points. When backed by strong financials and solid...
NasdaqGS:KRT
NasdaqGS:KRTTrade Distributors

Unveiling US Undiscovered Gems in February 2026

As February 2026 begins, U.S. stock indexes have shown a strong start to the month, with key indices like the Dow Jones and S&P 500 climbing significantly, reflecting positive market sentiment despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this dynamic environment, identifying promising small-cap stocks requires careful consideration of factors like market resilience and potential for growth amidst broader economic shifts.
NYSE:DDS
NYSE:DDSMultiline Retail

3 Reliable Dividend Stocks To Consider Yielding Up To 4.8%

As February begins, major U.S. stock indexes have shown strong performance, with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. In this dynamic market environment, dividend stocks can offer stability and income potential, making them an attractive option for investors seeking reliable returns amidst fluctuating market conditions.
NYSE:ESI
NYSE:ESIChemicals

Element Solutions Micromax Deal Reshapes Growth Drivers And Valuation Case

Element Solutions (NYSE:ESI) has completed its acquisition of Micromax, expanding its specialty chemicals portfolio for advanced electronics applications. The company has amended its credit facilities, adding new term loans and increasing revolving credit capacity to support the transaction and future initiatives. Element Solutions, a specialty chemicals supplier to the electronics and industrial markets, is taking a bigger role in the tech hardware supply chain with the Micromax deal. The...
NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

NXP Semiconductors (NXPI) Margin Decline Challenges Bullish Earnings Growth Narratives

NXP Semiconductors (NXPI) just wrapped up FY 2025 with Q4 revenue of US$3.3b and basic EPS of US$1.80, anchored by net income of US$455m, setting the stage for how investors read the year as a whole. The company has seen quarterly revenue move from US$3.1b in Q4 2024 to US$3.3b in Q4 2025, alongside quarterly EPS shifting from US$1.95 to US$1.80, which feeds into trailing twelve month EPS of US$8.00 on revenue of US$12.3b. With trailing net income of US$2.0b and a reported net margin that has...
OTCPK:SGMO
OTCPK:SGMOBiotechs

What Sangamo Therapeutics (SGMO)'s Fabry Gene Therapy Progress And Equity Raise Means For Shareholders

Sangamo Therapeutics recently reported detailed Phase 1/2 STAAR study results for its Fabry disease gene therapy, isaralgagene civaparvovec, and confirmed a rolling Biologics License Application submission to the FDA under the Accelerated Approval pathway, supported by kidney function as an intermediate clinical endpoint. The company paired these clinically promising data and regulatory progress with a roughly US$24.82 million follow-on equity raise and a finance leadership change,...
NYSE:HMN
NYSE:HMNInsurance

Is Horace Mann Educators (HMN) Price Justified After 5-Year 36.7% Share Return?

If you are wondering whether Horace Mann Educators at around US$44.92 still offers value, an important question is how its current price compares with what the business may be worth. The stock has returned 4.7% over the last 7 days, while the 1 year return sits at 21.7% and the 3 year return at 38.6%. A 0.6% decline year to date may suggest that expectations and risk perceptions are changing. Recent coverage has focused on Horace Mann Educators as an insurer serving the education community,...